This review describes the role of obesity in endocrine-related cancers, such as prostate cancer, breast cancer and pancreatic cancer, focusing on the mechanism of IGF-1 and the crosstalk with estrogen and adipokines. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.